By Therapeutic Area

Infectious Disease (Viral HAI) Market Analysis

Cross-industry research covering Infectious Disease (Viral HAI) across 1 market reportspanning Pharmaceuticals.

1 Reports

1 Industries

Reports Covering Infectious Disease (Viral HAI)

Hospital Acquired Infection Control Market to Reach USD 41.6B by 2033 at 6.4% CAGR

Pharmaceuticals·Market: USD 25.3 Billion (2025)·CAGR: 6.4%

Post-pandemic nosocomial respiratory virus control. RSV, influenza, and residual SARS-CoV-2 variants, sustains antiviral prophylaxis procurement, particularly in immunocompromised inpatient populations undergoing hematopoietic cell transplantation (nct:NCT05470491). Long-acting antiviral regimens in HIV-positive inpatient cohorts (nct:NCT06518408) create a niche but growing demand segment.

10%

Market Share

5.8%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments